Pneumonia: Clinical Trials

108 trials for Pneumonia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

108 unknown. 108 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 4108Unknown 108

Follow Pneumonia: new trials by email Literature Review of Pneumonia trials Research Report on Pneumonia

Trials (filtered) newest first · largest first

All 108 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Immunogenicity of rVSVΔG-ZEBOV-GP Vaccination When Dosed Concurrently With mRNA COVID-19 Vaccine Booster Doses
BioNTech - Pfizer COVID-19 vaccine, 1mL saline solution, rVSV∆G-ZEBOV-GP - Ebola Virus Disease, COVID-19
Phase 4UnknownUniversity of Birmingham722024-10-012024-09-19
Oral Care With 3% Hydrogen Peroxide (Oroxid®) in ICU - Effects on the Lower Airway Microbial Colonisation
Oroxid®, Chlorhexidine mouthwash - VAP - Ventilator Associated Pneumonia
Phase 4UnknownCharles University, Czech Republic1602024-05-012024-07-26
Optimizing Care for Children Hospitalized With Community-acquired Pneumonia: Short-course Therapy
Placebo, Amoxicillin - Community-acquired Pneumonia
Phase 4UnknownJeffrey752024-04-172024-12-12
Study of the Efficacy and Safety of Antioxidants Astaxanthin as an Adjuvant Therapy for Community Acquired Pneumonia Patients.
Astaxanthin Oral Capsule, Placebo - Community-acquired Pneumonia
Phase 4UnknownFuture University in Egypt802024-04-012024-04-12
Immunogenicity of Concomitant Administration of COVID-19 Vaccines With Influenza Vaccines
Omicron-containing COVID-19 vaccine, influenza vaccine - COVID-19, Influenza
Phase 4UnknownCatholic Kwandong University622023-09-252024-03-26
Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine Coadministered With Two Attenuated Vaccines
Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine, Inactivated SARS-CoV-2 vaccine coadministered with MMR, Inactivated SARS-CoV-2 vaccine administered alone - SARS-CoV-2 Infection, Varicella
Phase 4UnknownShanghai Municipal Center for Disease Control and Prevention5402023-08-012023-07-19
Efficiency and Safety of Paxlovid for COVID-19 Patients With Severe Chronic Kidney Disease
Nirmatrelvir/ritonavir - COVID-19, Renal Insufficiency, Chronic
Phase 4UnknownChinese PLA General Hospital302023-06-222023-07-10
Ivabradine for Long-Term Effects of COVID-19 With POTS Cohort
Ivabradine - Long Haul COVID, Postural Orthostatic Tachycardia Syndrome
Phase 4UnknownUniformed Services University of the Health Sciences2502023-06-142023-11-29
Effectiveness of a Second COVID-19 Vaccine Booster in Chinese Adults
Intramuscularly administered Ad5-nCoV vaccine, Aerosolized Ad5-nCoV, DelNS1-2019-nCoV-RBD-OPT1 - COVID-19
Phase 4UnknownJiangsu Province Centers for Disease Control and Prevention100002023-05-182023-05-22
Postoperative Sugammadex After COVID-19
Sugammadex Sodium, neostigmine 50µg/kg + glycopyrollate 0.01mg/kg - General Anesthesia, COVID-19
Phase 4UnknownKorea University Ansan Hospital3002023-04-202023-04-18
Research on the Treatment of Severe Community-acquired Pneumonia in Children
Prednisolone Acetate, placebo - Severe Pneumonia
Phase 4UnknownBaoping XU1602023-03-102023-03-14
Concomitant Administration of the Novavax Vaccine and a 20-valent Pneumococcal Conjugate Vaccine in Adults Aged ≥60 Years
NVX, PCV20, Placebo - COVID-19, Pneumococcal Infections
Phase 4UnknownMedical University of Vienna2562023-03-012023-03-15
A Study of Efficacy and Safety of Azvudine vs. Nirmatrelvir-Ritonavir in the Treatment of COVID-19 Infection
Azvudine, Nirmatrelvir-Ritonavir - COVID-19
Phase 4UnknownShandong Provincial Hospital4102023-01-212023-02-27
The Effect of Zoledronate on the Prevention of Pneumonia in Hip Fracture Patients
Zoledronate - Hip Fractures, Pneumonia
Phase 4UnknownThe University of Hong Kong26922022-12-052024-02-20
Immunogenicity and Safety of BBIBP-Corv Coadministered With PPV23 and IIV4 in Hemodialysis Population
coadministration, COVID-19 vaccine, IIV4+PPV23 - Hemolysis, COVID-19
Phase 4UnknownChina National Biotec Group Company Limited12002022-08-052022-08-30
Fourth Dose of mRNA COVID-19 Vaccine in Residents of LTCFs
mRNA- COVID-19, Prevnar13 - SARS-CoV2 Infection, Coronavirus Infection
Phase 4UnknownMark Loeb4142022-08-012022-06-30
Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine (Sinopharm BBIBP-CorV) Coadministered With Rabies Vaccine
coadministration, COVID-19 vaccine, rabies vaccine - COVID-19, Rabies
Phase 4UnknownChina National Biotec Group Company Limited3602022-07-212022-07-29
The Efficacy and Safety of BioBlock® Intranasally Administered Virus-Neutralizing Bovine Colostrum Nasal Spray in Preventing of COVID-19 (Coronavirus Disease-19) Infection in Healthy Volunteer Individuals
BioBlock® antiviral nasal spray - SARS CoV 2 Infection
Phase 4UnknownChemi-Pharm AS20002022-05-012023-02-08
Immunogenicity,Safety and Cross - Immune Response With Mutant Strains of a Third Dose of an Inactivated COVID-19 Vaccine
Inactivated COVID-19 Vaccine - COVID-19
Phase 4UnknownSinovac Life Sciences Co., Ltd.1802022-04-192023-11-07
Safety Study of COVID19 Vaccine on the Market
Recombinant new coronavirus vaccine (CHO cell) - COVID-19
Phase 4UnknownAnhui Zhifei Longcom Biologic Pharmacy Co., Ltd.1000002022-04-022023-06-06

Showing 20 of 108. Sign in to see all of them.

Narrower conditions

COVID-19 (77)  ·  Community-Acquired Pneumonia (9)  ·  Pneumonia, Ventilator-Associated (4)  ·  Pulmonary Disease, Chronic Obstructive (4)  ·  Bronchitis, Chronic (3)  ·  HIV Infections (3)  ·  Post-Acute COVID-19 Syndrome (3)  ·  Coronavirus Infections (2)  ·  Death (2)  ·  Diarrhea (2)  ·  Healthcare-Associated Pneumonia (2)  ·  Influenza, Human (2)  ·  Pneumonia, Pneumococcal (2)  ·  Pneumonia, Pneumocystis (2)

Broader conditions

Infections (108)  ·  Respiratory Tract Diseases (108)  ·  Respiratory Tract Infections (108)  ·  Lung Diseases (100)  ·  Virus Diseases (80)  ·  RNA Virus Infections (79)  ·  Coronaviridae Infections (78)  ·  Nidovirales Infections (78)  ·  Pneumonia, Viral (78)  ·  Coronavirus Infections (76)  ·  Pathological Conditions, Signs and Symptoms (23)  ·  Pathologic Processes (22)  ·  Disease Attributes (16)  ·  Community-Acquired Infections (9)

Interventions

Hydroxychloroquine (8)  ·  Azithromycin (6)  ·  Saline Solution (6)  ·  sinovac COVID-19 vaccine (6)  ·  Lopinavir (5)  ·  Vaccines (5)  ·  Ivermectin (4)  ·  Methylprednisolone (4)  ·  BNT162 Vaccine (3)  ·  COVID-19 Vaccines (3)  ·  Dexamethasone (3)  ·  Doxycycline (3)  ·  Levofloxacin (3)  ·  Moxifloxacin (3)  ·  Standard of Care (3)

Sponsors

China National Biotec Group Company Limited (10)  ·  Shahid Beheshti University of Medical Sciences (4)  ·  ClinAmygate (3)  ·  Ain Shams University (2)  ·  Assiut University (2)  ·  Clinical Urology and Epidemiology Working Group (2)  ·  Jiangsu Province Centers for Disease Control and Prevention (2)  ·  Seoul National University Hospital (2)  ·  Shandong Provincial Hospital (2)  ·  Sinovac Research and Development Co., Ltd. (2)  ·  The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) (2)  ·  Ahmed Essam (1)  ·  Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. (1)  ·  Ariel Dogliotti (1)  ·  Baoping XU (1)

Countries

China (31)  ·  Egypt (10)  ·  Brazil (5)  ·  Spain (5)  ·  United States (5)  ·  Iran (4)  ·  Argentina (3)  ·  Canada (3)  ·  South Korea (3)  ·  Finland (2)  ·  Israel (2)  ·  Kenya (2)  ·  Qatar (2)  ·  United Kingdom (2)  ·  Cameroon (1)

Top investigators

Hanqing He (4)  ·  Seyed Sina Naghibi Irvani, MD, MPH, MBA (4)  ·  Ilad Alavi Darazam, MD (2)  ·  Jing-Xin Li, PhD (2)  ·  Kari AO Tikkinen, MD PhD (2)  ·  Mehran Lack, MD (2)  ·  Minoosh Shabani, MD (2)  ·  Mohammad Fathi, MD (2)  ·  Mohammadreza Haji Esmaelie, MD (2)  ·  Nader Markazi, MD (2)  ·  Nasser Malekpour Alamdari, MD (2)  ·  Sanaz Zargar Balaye Jam, MD (2)  ·  Sasan Tavana, MD (2)  ·  Shervin Shokouhi, MD (2)  ·  Xianfeng Zhang (2)

Results publications

PMID 35244208, PMID 34473343, PMID 11778260, PMID 11888973, PMID 16236878, PMID 17604300, PMID 17872488, PMID 20729232, PMID 21478738, PMID 23398868, PMID 24465570, PMID 26083474, PMID 28426811, PMID 28473851, PMID 32641154, PMID 32895056, PMID 33072620, PMID 34273635, PMID 34559992, PMID 34561086, PMID 34629893, PMID 34635537, PMID 34658014, PMID 34764044, PMID 35152295, PMID 35177066, PMID 35247264, PMID 35798520, PMID 36513665, PMID 36695483, PMID 36875134, PMID 36936952, PMID 37591523, PMID 37977159, PMID 39308871, PMID 39523878, PMID 39539144, PMID 39756693, PMID 40257829, PMID 40692561, PMID 40838719, PMID 40852606, PMID 40976661, PMID 41285436, PMID 41489779, PMID 41542944, PMID 41698388, PMID 42329996, PMID 42743942, PMID 42827549

NIH funding

R01HD079695 (1)